U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Substance Class Protein
Created
by admin
on Sat Dec 16 01:11:33 GMT 2023
Edited
by admin
on Sat Dec 16 01:11:33 GMT 2023
Protein Type MONOCLONAL ANTIBODY
Protein Sub Type IGG1
Sequence Origin HUMANIZED MOUSE
Sequence Type COMPLETE
Record UNII
CUJ2MVI71Y
Record Status Validated (UNII)
Record Version
  • Download
Related Record Type
Name Type Language
DACLIZUMAB
DASH   EMA EPAR   INN   MART.   MI   USAN   VANDF   WHO-DD  
USAN   INN  
Official Name English
DACLIZUMAB [USAN]
Common Name English
Daclizumab [WHO-DD]
Common Name English
DACLIZUMAB [VANDF]
Common Name English
DACLIZUMAB [MART.]
Common Name English
daclizumab [INN]
Common Name English
RO-24-7375
Code English
DACLIZUMAB [PURPLE BOOK CDER]
Common Name English
ZINBRYTA
Common Name English
RO 24-7375
Code English
DACLIXIMAB
Common Name English
DACLIZUMAB [EMA EPAR]
Common Name English
DACLIZUMAB [MI]
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C574
Created by admin on Sat Dec 16 01:11:34 GMT 2023 , Edited by admin on Sat Dec 16 01:11:34 GMT 2023
NDF-RT N0000175621
Created by admin on Sat Dec 16 01:11:34 GMT 2023 , Edited by admin on Sat Dec 16 01:11:34 GMT 2023
WHO-ATC L04AC01
Created by admin on Sat Dec 16 01:11:34 GMT 2023 , Edited by admin on Sat Dec 16 01:11:34 GMT 2023
LIVERTOX NBK548018
Created by admin on Sat Dec 16 01:11:34 GMT 2023 , Edited by admin on Sat Dec 16 01:11:34 GMT 2023
NDF-RT N0000175622
Created by admin on Sat Dec 16 01:11:34 GMT 2023 , Edited by admin on Sat Dec 16 01:11:34 GMT 2023
NDF-RT N0000175621
Created by admin on Sat Dec 16 01:11:34 GMT 2023 , Edited by admin on Sat Dec 16 01:11:34 GMT 2023
WHO-VATC QL04AC01
Created by admin on Sat Dec 16 01:11:34 GMT 2023 , Edited by admin on Sat Dec 16 01:11:34 GMT 2023
EMA ASSESSMENT REPORTS ZENAPAX (WITHDRAWN: GRAFT REJECTION)
Created by admin on Sat Dec 16 01:11:34 GMT 2023 , Edited by admin on Sat Dec 16 01:11:34 GMT 2023
FDA ORPHAN DRUG 67692
Created by admin on Sat Dec 16 01:11:34 GMT 2023 , Edited by admin on Sat Dec 16 01:11:34 GMT 2023
EMA ASSESSMENT REPORTS ZENAPAX (WITHDRAWN: KIDNEY TRANSPLANTATION)
Created by admin on Sat Dec 16 01:11:34 GMT 2023 , Edited by admin on Sat Dec 16 01:11:34 GMT 2023
NCI_THESAURUS C20401
Created by admin on Sat Dec 16 01:11:34 GMT 2023 , Edited by admin on Sat Dec 16 01:11:34 GMT 2023
NDF-RT N0000010279
Created by admin on Sat Dec 16 01:11:34 GMT 2023 , Edited by admin on Sat Dec 16 01:11:34 GMT 2023
FDA ORPHAN DRUG 67792
Created by admin on Sat Dec 16 01:11:34 GMT 2023 , Edited by admin on Sat Dec 16 01:11:34 GMT 2023
Code System Code Type Description
RXCUI
190353
Created by admin on Sat Dec 16 01:11:34 GMT 2023 , Edited by admin on Sat Dec 16 01:11:34 GMT 2023
PRIMARY RxNorm
MERCK INDEX
m4066
Created by admin on Sat Dec 16 01:11:34 GMT 2023 , Edited by admin on Sat Dec 16 01:11:34 GMT 2023
PRIMARY Merck Index
ChEMBL
CHEMBL1201605
Created by admin on Sat Dec 16 01:11:34 GMT 2023 , Edited by admin on Sat Dec 16 01:11:34 GMT 2023
PRIMARY
NCI_THESAURUS
C1569
Created by admin on Sat Dec 16 01:11:34 GMT 2023 , Edited by admin on Sat Dec 16 01:11:34 GMT 2023
PRIMARY
DRUG BANK
DB00111
Created by admin on Sat Dec 16 01:11:34 GMT 2023 , Edited by admin on Sat Dec 16 01:11:34 GMT 2023
PRIMARY
FDA UNII
CUJ2MVI71Y
Created by admin on Sat Dec 16 01:11:34 GMT 2023 , Edited by admin on Sat Dec 16 01:11:34 GMT 2023
PRIMARY
USAN
FF-43 2
Created by admin on Sat Dec 16 01:11:34 GMT 2023 , Edited by admin on Sat Dec 16 01:11:34 GMT 2023
PRIMARY
LACTMED
Daclizumab
Created by admin on Sat Dec 16 01:11:34 GMT 2023 , Edited by admin on Sat Dec 16 01:11:34 GMT 2023
PRIMARY
WIKIPEDIA
DACLIZUMAB
Created by admin on Sat Dec 16 01:11:34 GMT 2023 , Edited by admin on Sat Dec 16 01:11:34 GMT 2023
PRIMARY
SMS_ID
100000085411
Created by admin on Sat Dec 16 01:11:34 GMT 2023 , Edited by admin on Sat Dec 16 01:11:34 GMT 2023
PRIMARY
EVMPD
SUB06885MIG
Created by admin on Sat Dec 16 01:11:34 GMT 2023 , Edited by admin on Sat Dec 16 01:11:34 GMT 2023
PRIMARY
CAS
152923-56-3
Created by admin on Sat Dec 16 01:11:34 GMT 2023 , Edited by admin on Sat Dec 16 01:11:34 GMT 2023
PRIMARY
IUPHAR
6880
Created by admin on Sat Dec 16 01:11:34 GMT 2023 , Edited by admin on Sat Dec 16 01:11:34 GMT 2023
PRIMARY
INN
7164
Created by admin on Sat Dec 16 01:11:34 GMT 2023 , Edited by admin on Sat Dec 16 01:11:34 GMT 2023
PRIMARY
MESH
C096001
Created by admin on Sat Dec 16 01:11:34 GMT 2023 , Edited by admin on Sat Dec 16 01:11:34 GMT 2023
PRIMARY
DRUG CENTRAL
4953
Created by admin on Sat Dec 16 01:11:34 GMT 2023 , Edited by admin on Sat Dec 16 01:11:34 GMT 2023
PRIMARY
ChEMBL
CHEMBL2108279
Created by admin on Sat Dec 16 01:11:34 GMT 2023 , Edited by admin on Sat Dec 16 01:11:34 GMT 2023
PRIMARY
From To
1_22 1_96
1_143 1_199
1_219 3_213
1_225 2_225
1_228 2_228
1_260 1_320
1_366 1_424
2_22 2_96
2_143 2_199
2_219 4_213
2_260 2_320
2_366 2_424
3_23 3_87
3_133 3_193
4_23 4_87
4_133 4_193
Glycosylation Type MAMMALIAN
Glycosylation Link Type Site
N 1_296
N 2_296
Related Record Type Details
SUB_CONCEPT->SUBSTANCE
TARGET -> AGONIST
TARGET -> INHIBITOR
Related Record Type Details
ACTIVE MOIETY
Name Property Type Amount Referenced Substance Defining Parameters References
Molecular Formula CHEMICAL
MOL_WEIGHT:SEQUENCE CHEMICAL
Biological Half-life PHARMACOKINETIC